Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Comment by Donbgamecockon Nov 14, 2019 8:34am

60 Views

Post# 30349527

RE:Canopy run down. Not good.

Daredevil1964 wrote:
Canopy Growth down 6% premarket on FQ2 miss, higher cash burn

Nov. 14, 2019 7:29 AM ET |About: Canopy Growth Corporation (CGC)|By: Mamta Mayani, SA News Editor

Canopy Growth (CGC) fiscal Q2 results (C$): Revenues: 76.6M (+228.8%); recreational cannabis revenue (business to business): 49.4M.

Kilogram and kg equivalents sold: 10,913 (+3% sequentially)

Net loss: (374.6M) (-13.3%); loss/share: (1.08) (+28.9%).

Non-GAAP EBITDA: (155.7M) (-151.5%).

Cash consumption: (359.3M) (-81.4%).

Shares are down 6% premarket.

Previously: Canopy Growth EPS misses by C$0.73, misses on revenue (Nov. 14)